Nanomedicine and Nanobiology
A section of Biomedicines (ISSN 2227-9059).
Section Information
This Section of Biomedicines aims to rapidly publish contributions on synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; and interactions of nanomaterials with cells, tissues, and living organisms.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Recent Advances in Nanomaterials for Cancer Detection: Progress, Challenges and Opportunities (Deadline: 31 May 2023)
- State-of-the-Art Nanomedicine and Nanobiotechnology in Europe (Deadline: 15 June 2023)
- Progress in Nanoformulations for Nanomedicine (Deadline: 15 June 2023)
- Preparation and Biomedical Application of Micro- and Nanocarriers of Active Substances (Deadline: 30 June 2023)
- Nano-Biomedicines for Neurological Disorders and Nerve Regeneration (Deadline: 15 July 2023)
- State-of-the-Art in Nanomedicine for Ischemic Stroke (Deadline: 15 July 2023)
- Nanoparticle-Based for Diagnostics and Therapies (Deadline: 31 July 2023)
- Nanomaterial-Based Contrast Agents for Biomedical Imaging (Deadline: 31 July 2023)
- Recent Developments and Future Prospects of Nanomedicine: Controlled and Targeted Drug-Delivery Systems for Anticancer Agents (Deadline: 31 August 2023)
- Advances in Nanomaterials for Drug Delivery 2.0 (Deadline: 31 August 2023)
- Bio-Nano Interfaces: From Biosensors to Nanomedicines (Deadline: 30 September 2023)
- Recent Advances in the Lipid Nanoparticles (Deadline: 30 September 2023)
- Advances in Nanomedicine for Disease Treatment and Diagnosis (Deadline: 30 September 2023)
- Advanced Research on Nanomaterials for Regenerative Medicine (Deadline: 31 October 2023)
- Nanobiomaterials with Anti-Bacterial and Anti-Cancer Applications (Deadline: 31 October 2023)
- Nanotechnology to Counter the Off-Target Toxicity of Therapeutics (Deadline: 31 December 2023)
